Details of the Drug

General Information of Drug (ID: DMK43ON)

Drug Name
Bendavia
Synonyms Elamipretide
Indication
Disease Entry ICD 11 Status REF
Mitochondrial myopathy 8C73 Phase 3 [1]
Acute myocardial infarction BA41 Phase 2 [2]
Heart failure BD10-BD13 Phase 2 [3]
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C32H49N9O5
Canonical SMILES
CC1=CC(=CC(=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCN=C(N)N)N)C)O
InChI
1S/C32H49N9O5/c1-19-15-22(42)16-20(2)23(19)18-27(41-29(44)24(34)11-8-14-38-32(36)37)31(46)39-25(12-6-7-13-33)30(45)40-26(28(35)43)17-21-9-4-3-5-10-21/h3-5,9-10,15-16,24-27,42H,6-8,11-14,17-18,33-34H2,1-2H3,(H2,35,43)(H,39,46)(H,40,45)(H,41,44)(H4,36,37,38)/t24-,25+,26+,27+/m1/s1
InChIKey
SFVLTCAESLKEHH-WKAQUBQDSA-N
Cross-matching ID
PubChem CID
11764719
CAS Number
736992-21-5
UNII
87GWG91S09
DrugBank ID
DB11981
TTD ID
D07TDV
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT01572909) Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events. U.S. National Institutes of Health.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)